Answer
Concurrent vemurafenib and ipilimumab is not recommended because preliminary Phase I trial data showed asymptomatic grade 3 increases in liver transaminases and bilirubin.
Sources for this answer
- Zelboraf 240 mg Film-coated TabletsRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 30Document updated
Sources checked